Submit Manuscript

A clear, efficient submission path for prevention research and care improvement.

JPMC provides a streamlined submission process designed for prevention researchers, clinicians, and public health professionals. Submissions are reviewed for scope fit, methodological rigor, and real world prevention impact.

Use ManuscriptZone to submit and track your manuscript. The editorial office is available to answer questions about scope, formatting, and required documentation.

A complete submission package helps reduce review delays and supports timely decisions and clear editorial review.

• Confirm that your study aligns with prevention and care outcomes
• Prepare ethics approvals and informed consent documentation
• Ensure data availability statements and registry identifiers are included
• Review reporting standards relevant to your study type
• Check that figures, tables, and supplementary files are complete

• Title page with author affiliations and corresponding author contact
• Structured abstract with objectives, methods, results, and conclusions
• Introduction framing the prevention problem and context
• Methods describing study design, population, and analysis
• Results with clear tables, figures, and outcome measures
• Discussion with implications for prevention practice or policy
• Data availability, ethics, and funding statements
• References in Vancouver style

Structured abstracts should summarize objectives, methods, results, and conclusions. Use keywords that reflect prevention focus and population impact to improve discoverability.

Select three to six keywords aligned with preventive medicine, public health, or care delivery terminology.

Include an authorship statement that reflects substantial contributions to study design, data collection, analysis, or writing. All authors should approve the final submission.

Contribution statements improve transparency and reduce authorship disputes.

• Study conception and design
• Data acquisition or analysis
• Manuscript drafting and revision
• Approval of the final version

• Use clear headings and consistent terminology
• Define abbreviations at first use
• Number pages and include line numbers if possible
• Provide high resolution figures with descriptive legends
• Ensure tables are cited in the text

• Upload figures as separate high resolution files
• Use clear labels and include descriptive legends
• Ensure tables are editable and referenced in the text
• Submit supplementary materials with concise descriptions
• Confirm de-identification of patient images

Clear writing improves review efficiency and helps prevention evidence reach practice audiences. Avoid unnecessary jargon and define technical terms on first use.

If you need language editing support, contact the editorial office before submission.

All human research must include ethics approval and informed consent. Clinical trials should include registration identifiers and report adverse events when relevant.

Animal studies must comply with institutional and national welfare standards.

• IRB or ethics committee approval details
• Consent procedures for human participants
• Trial registration numbers when applicable
• Conflict of interest disclosures

Use reporting standards that match your study design to improve transparency and review efficiency. Clear methods and reproducible analyses strengthen prevention evidence.

• CONSORT for randomized trials
• STROBE for observational studies
• PRISMA for systematic reviews and meta analyses
• TREND for non randomized evaluations when applicable

Interventional studies should include a public trial registration number and describe primary outcomes, timelines, and analytic plans.

If protocols are published or registered, include links or identifiers to support transparency.

• Describe sample size calculations and power where relevant
• Report confidence intervals alongside p values
• Explain handling of missing data and outliers
• Specify statistical software and version

• Provide repository links or access pathways for datasets
• Include analytic code when feasible
• Describe any restrictions on data reuse
• Link protocols or trial registrations when available

Ensure that participant privacy is protected and that any shared data are de-identified. For sensitive datasets, describe the access controls and governance processes.

If patient images are included, confirm written consent and remove identifying details.

Include funding sources, grant numbers, and sponsor roles. If no external funding was received, state this clearly.

Acknowledge contributors who do not meet authorship criteria to support transparency.

• Funding and sponsor role statement
• Conflict of interest disclosures
• Acknowledgments for technical or administrative support

• Explain scope fit and prevention impact
• Summarize the manuscript contribution and novelty
• List suggested reviewers with affiliations and emails
• Disclose related submissions or preprints
• Confirm funding and conflicts of interest

Preprints are allowed when disclosed in the cover letter and cited in the manuscript. Prior conference presentations should also be noted.

This transparency supports ethical publishing and prevents duplicate reporting.

Manuscripts are submitted through ManuscriptZone. Create an account, complete the submission form, and upload your files and supporting documents.

If you experience technical issues, contact the editorial office for assistance.

• Register or log in at https://oap.manuscriptzone.net
• Enter manuscript title, abstract, and keywords
• Upload manuscript, figures, tables, and supplementary files
• Complete author, funding, and ethics declarations
• Submit and track progress in your dashboard

• Initial editorial screening for scope and completeness
• Reviewer assignment based on topic and methods
• Single blind peer review with consolidated decision letter
• Revision requests with clear guidance
• Final decision by the editorial team

Address reviewer comments point by point and highlight changes in the revised manuscript. Clear responses help accelerate decisions and improve review efficiency.

If you disagree with a suggestion, provide a concise rationale supported by evidence.

• Response letter with point by point replies
• Revised manuscript with changes highlighted
• Updated figures or tables if requested
• Revised data availability or ethics statements when needed
• Confirmation that all authors approved the revision

Accepted manuscripts move to production for copyediting, formatting, and proof review. Authors review proofs to ensure accuracy in data, figures, and metadata.

Publication proceeds after APC confirmation. Details are available on the APC page and the editorial office can provide documentation for funders or institutions.

• Verify author names, affiliations, and funding statements
• Check tables, figures, and captions for accuracy
• Confirm that references and DOI links are complete
• Ensure supplementary files are final and referenced

Accurate metadata improves discoverability. Confirm author names, affiliations, funding details, and keywords during proof review so indexing services can capture your article correctly.

Provide DOI links for references when available to support citation tracking.

Reliable metadata also supports funder reporting and institutional dashboards.

Open access publication enables immediate sharing with clinicians, program leaders, and policy teams. Authors are encouraged to share published articles through institutional repositories and professional networks.

Strong metadata and clear abstracts also improve search engine discovery and long term citation performance.

Highlighting prevention outcomes in summaries helps reach practice audiences.

JPMC publishes open access and applies APCs after acceptance. Membership options and institutional arrangements may be available for eligible authors.

For APC details or invoicing support, contact the editorial office.

Early coordination helps keep production on schedule.

• APC details: https://openaccesspub.org/journal/preventive-medicine-and-care/article-processing-charges
• Editorial office: [email protected]

• Missing ethics approvals or consent details
• Incomplete data availability statements
• Figures or tables not referenced in text
• Unclear authorship or missing affiliations
• Inconsistent formatting or missing declarations

The editorial office can clarify scope fit, formatting requirements, or data reporting expectations before submission. Early communication helps prevent delays and improves review efficiency.

For technical issues in ManuscriptZone or questions about documentation, contact [email protected].

We aim to respond promptly with clear next steps.

• Scope fit and prevention relevance confirmed
• Ethics approval and consent included
• Data availability statement completed
• Abstract and keywords aligned with prevention focus
• Figures and tables labeled and cited
• Cover letter prepared
• Funding and conflict disclosures complete

JPMC supports authors, editors, and reviewers with timely guidance on scope, policies, and workflows. If you need clarification on requirements, data statements, or review timelines, contact the editorial office at [email protected]. We can provide templates, examples, and best-practice recommendations to help you move forward confidently. Our responses typically include next steps, resource links, and a clear point of contact. Early communication helps avoid delays, ensures consistent compliance, and improves the overall publication experience.